Related references
Note: Only part of the references are listed.Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats
Tsung-Ming Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Inhalation of endothelin receptor blockers in pulmonary hypertension
Hanno H. Leuchte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Inflammatory response and white matter damage after macroinjections of endothelin-1 into the rat striatum
R. D. Souza-Rodrigues et al.
BRAIN RESEARCH (2008)
The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?
N. S. Kirkby et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The endothelin axis in cancer:: the promise and the challenges of molecularly targeted therapy
Anna Bagnato et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2008)
Role of the renin-angiotensin-aidosterone system in collecting duct-derived endothelin-1 regulation of blood pressure
Yuqiang Ge et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2008)
Enzymatic activity of lysosomal carboxypeptidase (cathepsin) a is required for proper elastic fiber formation and inactivation of endothelin-1
Volkan Seyrantepe et al.
CIRCULATION (2008)
Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus
Claudete M. Zanatta et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide
Markus P. Schneider et al.
HYPERTENSION (2008)
Endothelins are vascular-derived axonal guidance cues for developing sympathetic neurons
Takako Makita et al.
NATURE (2008)
Reversal of proteinuric renal disease and the emerging role of endothelin
Matthias Barton
NATURE CLINICAL PRACTICE NEPHROLOGY (2008)
Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells
Federica Collino et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Vascular peptide endothelin-1 links fat accumulation with alterations of visceral adipocyte lipolysis
Vanessa van Harmelen et al.
DIABETES (2008)
Experience with inhaled iloprost and bosentan in portopulmonary hypertension
M. M. Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review
Sheridan Henness et al.
CURRENT OPINION IN RHEUMATOLOGY (2007)
Reversal of renal disease: is it enough to inhibit the action of angiotensin II?
J-C Dussaule et al.
CELL DEATH AND DIFFERENTIATION (2007)
Improvement of vascular endothelial function using the oral endothelin receptor antagonist Bosentan in patients with systemic sclerosis
P. P. Sfikakis et al.
ARTHRITIS AND RHEUMATISM (2007)
Pulmonary arterial hypertension: current therapeutic strategies
Aniket Puri et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2007)
Endothelin limits insulin action in obese/insulin-resistant humans
Amale Lteif et al.
DIABETES (2007)
Drug discovery for heart failure: a new era or the end of the pipeline?
David M. Kaye et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: Implications for diet-induced obesity
Alexa L. Mundy et al.
CARDIOVASCULAR RESEARCH (2007)
Therapeutic targets in systemic sclerosis
Christopher P. Denton
ARTHRITIS RESEARCH & THERAPY (2007)
Regulation of kidney acid excretion by endothelins
D. E. Wesson
KIDNEY INTERNATIONAL (2006)
Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling
Marina Morigi et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension
Martin Opocensky et al.
HYPERTENSION (2006)
Endothelin-1 inhibits adipogenesis: Role of phosphorylation of Akt and ERK1/2
Indranil Bhattacharya et al.
FEBS LETTERS (2006)
Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions
C. P. Denton et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes
Andrew Proven et al.
JOURNAL OF CELL SCIENCE (2006)
Reversal of renal lesions following interruption of nitric oxide synthesis inhibition in transgenic mice
S Placier et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Endothelin-2 in ovarian follicle rupture
C Ko et al.
ENDOCRINOLOGY (2006)
The renal medullary endothelin system in control of sodium and water excretion and systemic blood pressure
DE Kohan
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2006)
Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats
N Berthiaume et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Regression of medial elastocalcinosis in rat aorta - A new vascular function for carbonic anhydrase
R Essalihi et al.
CIRCULATION (2005)
Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes:: Evidence for endothelin release by pancreatic islet β-cells
J Ortmann et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients
RL Cauduro et al.
CLINICAL TRANSPLANTATION (2005)
Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?
C Chatziantoniou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Vascular endothelin in hypertension
EL Schiffrin
VASCULAR PHARMACOLOGY (2005)
In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene - Implication for permselective dysfunction of chronic nephropathies
M Morigi et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Activation of pro-inflammatory and anti-inflammatory cytokines in host organs during chronic allograft rejection:: Role of endothelin receptor signaling
T Lattmann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Effect of bosentan (ETA/ETB receptor antagonist) on metabolic changes during stress and diabetes
SA Said et al.
PHARMACOLOGICAL RESEARCH (2005)
Endothelin receptor antagonists - Clinical realities and future directions
M Kirchengast et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition
J Ortmann et al.
HYPERTENSION (2004)
Digital ulcers in systemic sclerosis - Prevention by treatment with bosentan, an oral endothelin receptor antagonist
JH Korn et al.
ARTHRITIS AND RHEUMATISM (2004)
Mast cells promote homeostasis by limiting endothelin-1-induced toxicity
M Maurer et al.
NATURE (2004)
Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients
C Cardillo et al.
HYPERTENSION (2004)
Reduced pulmonary clearance of endothelin in congestive heart failure:: A marker of secondary pulmonary hypertension
C Staniloae et al.
JOURNAL OF CARDIAC FAILURE (2004)
Endothelin receptor blockers in cardiovascular disease
S Rich et al.
CIRCULATION (2003)
Management of pulmonary hypertension resulting from interstitial lung disease
S Shapiro
CURRENT OPINION IN PULMONARY MEDICINE (2003)
Endothelin-1-stimulated glucose uptake is desensitized by tumor necrosis factor-α in 3T3-L1 adipocytes
N Rachdaoui et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Obesity-associated activation of angiotensin and endothelin in the cardiovascular system
M Barton et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
The endothelin system and its role in acute myocardial infarction
P Cernacek et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2003)
Endothelin and endothelin receptor antagonists in systemic rheumatic disease
MD Mayes
ARTHRITIS AND RHEUMATISM (2003)
Pulmonary hypertension in systemic sclerosis
CP Denton et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2003)
Vascular inflammation: a role in vascular disease in hypertension?
A Virdis et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2003)
Endothelin-1: a multifunctional molecule in cancer
K Grant et al.
BRITISH JOURNAL OF CANCER (2003)
Combination treatment with an ETA-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models
SR Orth et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
New therapeutics that antagonize endothelin: Promises and frustrations
G Remuzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression
T Traupe et al.
JOURNAL OF HYPERTENSION (2002)
Is urotensin-II the new endothelin?
JJ Maguire et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Beyond blood pressure: The endothelium and atherosclerosis progression
EL Schiffrin
AMERICAN JOURNAL OF HYPERTENSION (2002)
Darusentan:: An effective endothelinA receptor antagonist for treatment of hypertension
R Nakov et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
Endothelin A receptor antagonist LU 135252 inhibits hypercholesterolemia-induced, but not deendothelialization-induced, atherosclerosis in rabbit arteries
G Tepe et al.
INVESTIGATIVE RADIOLOGY (2002)
International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature
AP Davenport
PHARMACOLOGICAL REVIEWS (2002)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Proinflammatory effects of angiotensin II and endothelin: targets for progression of cardiovascular and renal diseases
FC Luft
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2002)
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study
RN Channick et al.
LANCET (2001)
Endothelin antagonists for chronic heart failure: do they have a role?
PJ Cowburn et al.
EUROPEAN HEART JOURNAL (2001)
Role of endothelin-1 in hypertension and vascular disease
EL Schiffrin
AMERICAN JOURNAL OF HYPERTENSION (2001)
Effects of urotensin II in human arteries and veins of varying caliber
C Hillier et al.
CIRCULATION (2001)
Regression of renal vascular fibrosis by endothelin receptor antagonism
JJ Boffa et al.
HYPERTENSION (2001)
Endothelin and cardiac arrhythmias:: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs?
F Duru et al.
CARDIOVASCULAR RESEARCH (2001)
Renoprotective therapy in patients with nondiabetic nephropathies
R Pisoni et al.
DRUGS (2001)
Endothelin system: The double-edged sword in health and disease
RM Kedzierski et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Blockade of endothelin receptors reduces diet-induced hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice
S Iwasa et al.
PATHOBIOLOGY (2001)
Endothelins and endothelin receptor antagonists -: Therapeutic considerations for a novel class of cardiovascular drugs
TF Lüscher et al.
CIRCULATION (2000)
Renal tubular effects of endothelin-B receptor signaling: its role in cardiovascular homeostasis and extracellular volume regulation
T Ohuchi et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2000)
Hypertension in black patients - An emerging role of the endothelin system in salt-sensitive hypertension
A Ergul
HYPERTENSION (2000)
Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development
H Yanagisawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Salt-sensitive hypertension in endothelin-B receptor-deficient rats
CE Gariepy et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Inhaled endothelin A antagonist improves arterial oxygenation in experimental acute lung injury
U Kaisers et al.
INTENSIVE CARE MEDICINE (2000)
Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo - Evidence for a regulatory role of endothelin
M Barton et al.
HYPERTENSION (2000)
Share Paper
